Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
将全反式维甲酸重新用作胰腺癌基质靶向剂的 I 期临床试验
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-020-18636-w
Hemant M Kocher, Bristi Basu, Fieke E M Froeling, Debashis Sarker, Sarah Slater, Dominic Carlin, Nandita M deSouza, Katja N De Paepe, Michelle R Goulart, Christine Hughes, Ahmet Imrali, Rhiannon Roberts, Maria Pawula, Richard Houghton, Cheryl Lawrence, Yathushan Yogeswaran, Kelly Mousa, Carike Coetz
